# Osamu Ogawa

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/osamu-ogawa/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,566 |
| Field | Prostate Cancer Treatment and Research |
| h-index | 76 |
| i10-index | 477 |
| Last Known Institution | Kyoto University |
| OpenAlex ID | https://openalex.org/A5083025134 |
| ORCID iD | 0000-0003-3651-5455 |
| Works | 1,168 |

## Researcher papers

Showing 12 of 13.

- [Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour](https://scholariq.org/papers/relaxation-of-insulin-like-growth-factor-ii-gene-imprinting-implicated-in-wilms/)
- [Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases](https://scholariq.org/papers/large-scale-genome-wide-association-study-in-a-japanese-population-identifies/)
- [Mitochondrial Genome Variation in Eastern Asia and the Peopling of Japan](https://scholariq.org/papers/mitochondrial-genome-variation-in-eastern-asia-and-the-peopling-of-japan/)
- [Gene Expression Levels and Immunolocalization of Organic Ion Transporters in the Human Kidney](https://scholariq.org/papers/gene-expression-levels-and-immunolocalization-of-organic-ion-transporters-in-the/)
- [Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial](https://scholariq.org/papers/durvalumab-alone-and-durvalumab-plus-tremelimumab-versus-chemotherapy-in/)
- [Salt-sensitive hypertension in circadian clock–deficient Cry-null mice involves dysregulated adrenal Hsd3b6](https://scholariq.org/papers/salt-sensitive-hypertension-in-circadian-clock-deficient-cry-null-mice-involves/)
- [Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H+-organic cation antiporters](https://scholariq.org/papers/substrate-specificity-of-mate1-and-mate2-k-human-multidrug-and-toxin-extrusions/)
- [Identification and Functional Characterization of a New Human Kidney–Specific H+/Organic Cation Antiporter, Kidney-Specific Multidrug and Toxin Extrusion 2](https://scholariq.org/papers/identification-and-functional-characterization-of-a-new-human-kidney-specific-h/)
- [Cortical Organization by the Septin Cytoskeleton Is Essential for Structural and Mechanical Integrity of Mammalian Spermatozoa](https://scholariq.org/papers/cortical-organization-by-the-septin-cytoskeleton-is-essential-for-structural-and/)
- [Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population](https://scholariq.org/papers/genome-wide-association-study-identifies-five-new-susceptibility-loci-for/)
- [Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism](https://scholariq.org/papers/prevalence-of-cardiovascular-disease-and-its-risk-factors-in-primary/)
- [Formation of 8‐hydroxy‐2′‐deoxyguanosine and 4‐hydroxy‐2‐nonenal‐modified proteins in human renal‐cell carcinoma](https://scholariq.org/papers/formation-of-8-hydroxy-2-deoxyguanosine-and-4-hydroxy-2-nonenal-modified/)

## Researcher topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Urinary Bladder and Prostate Research](https://scholariq.org/topics/urinary-bladder-and-prostate-research/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Researcher university

- [Kyoto University](https://scholariq.org/institutions/kyoto-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.